Back to MORGAN STANLEY MORGAN STANLEY

ROIVROIV
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ROIVANT SCIENCES LTD

MORGAN STANLEY holds 42.6M shares of ROIV (ROIVANT SCIENCES LTD), worth $1.5B as of 2026-Q2. The position was decreased (-17.8% shares). ROIV represents 0.1% of MORGAN STANLEY's portfolio.

Current Value

$1.5B

Current Shares

42.6M

Total Value Change

+$1.2B

Total Shares Change

+12.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
42.6M
-17.8%
$1.5B0.1%$35.39
0
2026-Q1
Decreased
51.8M
-11.2%
$1.4B0.1%$27.85
0
2025-Q4
Increased
58.4M
+31.7%
$1.3B0.1%$21.63
41
2025-Q3
Decreased
44.3M
-0.8%
$670.6M0.0%$15.10
0
2025-Q2
Increased
44.7M
+24.4%
$503.7M0.0%$11.39
38
2025-Q1
Increased
35.9M
+3.8%
$362.5M0.0%$10.38
32
2024-Q4
Increased
34.6M
+16.6%
$409.5M0.0%$11.43
36
2024-Q3
Increased
29.7M
+1.2%
$342.4M0.0%$11.48
31

Other major holders of ROIV: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used